P38 MAPK and PI3K/AKT Signalling Cascades InParkinson's Disease

Overview

Journal Int J Mol Cell Med

Specialty Genetics

Date 2015 Aug 12

PMID 26261796

Citations 88

Authors

Saurabh Kumar Jha

Niraj Kumar Jha

Rohan Kar

Rashmi K Ambasta

Pravir Kumar

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a chronic neurodegenerative condition which has the second largest incidence rate among all other neurodegenerative disorders barring Alzheimer's disease (AD). Currently there is no cure and researchers continue to probe the therapeutic prospect in cell cultures and animal models of PD. Out of the several factors contributing to PD prognosis, the role of p38 MAPK (Mitogen activated protein-kinase) and PI3K/AKT signalling module in PD brains is crucial because the impaired balance between the pro- apoptotic and anti-apoptotic pathways trigger unwanted phenotypes such as microglia activation, neuroinflammation, oxidative stress and apoptosis. These factors continue challenging the brain homeostasis in initial stages thereby essentially assisting the dopaminergic (DA) neurons towards progressive degeneration in PD. Neurotherapeutics against PD shall then be targeted against the misregulated accomplices of the p38 and PI3K/AKT cascades. In this review, we have outlined many such established mechanisms involving the p38 MAPK and PI3K/AKT pathways which can offer therapeutic windows for the rectification of aberrant DA neuronal dynamics in PD brains.

Citing Articles

Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in Mice.

Soni R, Mathur K, Rathod H, Khairnar A, Shah J ACS Pharmacol Transl Sci. 2024; 7(12):4155-4164.

PMID: 39698281 PMC: 11650731. DOI: 10.1021/acsptsci.4c00586.

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.

Toader C, Tataru C, Munteanu O, Serban M, Covache-Busuioc R, Ciurea A Int J Mol Sci. 2024; 25(23.

PMID: 39684324 PMC: 11641752. DOI: 10.3390/ijms252312613.

A comprehensive review of natural compounds and their structure-activity relationship in Parkinson's disease: exploring potential mechanisms.

Merghany R, El-Sawi S, Naser A, Ezzat S, Moustafa S, Meselhy M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39392484 DOI: 10.1007/s00210-024-03462-4.

Exploring the potential mechanism of atrazine-induced dopaminergic neurotoxicity based on integration strategy.

Qi L, Yang J, Li J Environ Health Prev Med. 2024; 29:46.

PMID: 39231689 PMC: 11391274. DOI: 10.1265/ehpm.24-00079.

Unraveling the AKT/ERK cascade and its role in Parkinson disease.

Keshri P, Singh S Arch Toxicol. 2024; 98(10):3169-3190.

PMID: 39136731 DOI: 10.1007/s00204-024-03829-9.

References

Giuliani P, Romano S, Ballerini P, Ciccarelli R, Petragnani N, Cicchitti S . Protective activity of guanosine in an in vitro model of Parkinson's disease. Panminerva Med. 2012; 54(1 Suppl 4):43-51. View

Bega D, Zadikoff C . Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices. J Mov Disord. 2014; 7(2):57-66. PMC: 4213533. DOI: 10.14802/jmd.14009. View

Kettenmann H, Hanisch U, Noda M, Verkhratsky A . Physiology of microglia. Physiol Rev. 2011; 91(2):461-553. DOI: 10.1152/physrev.00011.2010. View

Fonseca C, Gama S, Saavedra A, Baltazar G . H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways. Biochim Biophys Acta. 2014; 1842(7):927-34. DOI: 10.1016/j.bbadis.2014.03.003. View

Kim S, Chung E, Bok E, Baik H, Chung Y, Won S . Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation. J Neurosci Res. 2009; 88(7):1537-48. DOI: 10.1002/jnr.22318. View

Jung U, Kim S . Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain. Neural Regen Res. 2014; 9(16):1514-7. PMC: 4192967. DOI: 10.4103/1673-5374.139476. View

Oh C, Han B, Choi W, Youdim M, Oh Y . Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration. Apoptosis. 2011; 16(11):1087-100. DOI: 10.1007/s10495-011-0627-8. View

Murakami M, Ito H, Hagiwara K, Kobayashi M, Hoshikawa A, Takagi A . Sphingosine kinase 1/S1P pathway involvement in the GDNF-induced GAP43 transcription. J Cell Biochem. 2011; 112(11):3449-58. DOI: 10.1002/jcb.23275. View

Chong C, Zhou Z, Razmovski-Naumovski V, Cui G, Zhang L, Sa F . Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Neurosci Lett. 2013; 543:121-5. DOI: 10.1016/j.neulet.2013.02.069. View

10.

Oster S, Radad K, Scheller D, Hesse M, Balanzew W, Reichmann H . Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. Eur J Pharmacol. 2013; 724:31-42. DOI: 10.1016/j.ejphar.2013.12.014. View

11.

Wang L, Yang H, Xia Y, Feng Z . Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling. Apoptosis. 2010; 15(12):1470-9. DOI: 10.1007/s10495-010-0547-z. View

12.

Roux P, Blenis J . ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004; 68(2):320-44. PMC: 419926. DOI: 10.1128/MMBR.68.2.320-344.2004. View

13.

Kannarkat G, Boss J, Tansey M . The role of innate and adaptive immunity in Parkinson's disease. J Parkinsons Dis. 2013; 3(4):493-514. PMC: 4102262. DOI: 10.3233/JPD-130250. View

14.

Kim J, Byun J, Choi I, Kim B, Jeong H, Jou I . PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices. Exp Neurobiol. 2013; 22(1):38-44. PMC: 3620457. DOI: 10.5607/en.2013.22.1.38. View

15.

Uttara B, Singh A, Zamboni P, Mahajan R . Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009; 7(1):65-74. PMC: 2724665. DOI: 10.2174/157015909787602823. View

16.

Aron L, Klein P, Pham T, Kramer E, Wurst W, Klein R . Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. PLoS Biol. 2010; 8(4):e1000349. PMC: 2850379. DOI: 10.1371/journal.pbio.1000349. View

17.

Wang X, Zhang S, Yan Z, Zhao Y, Zhou H, Wang Y . Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. Free Radic Biol Med. 2011; 50(9):1094-106. DOI: 10.1016/j.freeradbiomed.2011.01.032. View

18.

Comalada M, Lloberas J, Celada A . MKP-1: a critical phosphatase in the biology of macrophages controlling the switch between proliferation and activation. Eur J Immunol. 2012; 42(8):1938-48. DOI: 10.1002/eji.201242441. View

19.

Richardson J, Hossain M . Microglial ion channels as potential targets for neuroprotection in Parkinson's disease. Neural Plast. 2013; 2013:587418. PMC: 3832972. DOI: 10.1155/2013/587418. View

20.

Chien W, Lee T, Hung S, Kang K, Lee M, Fu W . Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. J Neurochem. 2011; 117(4):643-53. DOI: 10.1111/j.1471-4159.2011.07229.x. View